Bellwether Advisors, LLC Zoetis Inc. Transaction History

Bellwether Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$165.67 - $199.94 $1.94 Million - $2.34 Million	11,722 New	11,722 $1.98 Million
Q4 2022 Feb 13, 2023	SELL	$131.14 - $157.47 $9,704 - $11,652	-74 Reduced 21.2%	275 $40,000
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $10,973 - $13,508	74 Added 26.91%	349 $51,000
Q2 2022 Aug 05, 2022	SELL	$155.97 - $200.09 $4,835 - $6,202	-31 Reduced 10.13%	275 $47,000
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $5,867 - $6,500	31 Added 11.27%	306 $59,000
Q2 2021 Aug 10, 2021	SELL	$155.9 - $187.99 $3,897 - $4,699	-25 Reduced 8.33%	275 $51,000
Q4 2020 Jan 29, 2021	BUY	$157.07 - $174.35 $47,121 - $52,305	300 New	300 $49,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.